Kee Woo-Sung, Celltrion
Celltrion to begin mass producing antibody treatment before getting approval
In the race for something — anything — to rein in the pandemic, Celltrion says it will begin mass-producing its potential Covid-19 antibody treatment this month. The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.